{"count": 8, "results": [{"_id": "11386927", "pmid": 11386927, "title": "Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.", "journal": "JAMA", "authors": ["Agodoa LY", "Appel L", "Bakris GL", "Beck G", "Bourgoignie J", "Briggs JP", "Charleston J", "Cheek D", "Cleveland W", "Douglas JG", "Douglas M", "Dowie D", "Faulkner M", "Gabriel A", "Gassman J", "Greene T", "Hall Y", "Hebert L", "Hiremath L", "Jamerson K", "Johnson CJ", "Kopple J", "Kusek J", "Lash J", "Lea J", "Lewis JB", "Lipkowitz M", "Massry S", "Middleton J", "Miller ER 3rd", "Norris K", "O'Connor D", "Ojo A", "Phillips RA", "Pogue V", "Rahman M", "Randall OS", "Rostand S", "Schulman G", "Smith W", "Thornley-Brown D", "Tisher CC", "Toto RD", "Wright JT Jr", "Xu S", "African American Study of Kidney Disease and Hypertension (AASK) Study Group"], "date": "2001-06-06T00:00:00Z", "doi": "10.1001/jama.285.21.2719", "meta_date_publication": "2001 Jun 6", "meta_volume": "285", "meta_issue": "21", "meta_pages": "2719-28", "score": 50084.188, "text_hl": "Effect of @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ vs @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on renal outcomes in @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@: a randomized controlled trial.", "citations": {"NLM": "Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S, African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA. 2001 Jun 6;285(21):2719-28. PMID: 11386927", "BibTeX": "@article{11386927, title={Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.}, author={Agodoa LY and Appel L and Bakris GL and Beck G and Bourgoignie J and Briggs JP and Charleston J and Cheek D and Cleveland W and Douglas JG and Douglas M and Dowie D and Faulkner M and Gabriel A and Gassman J and Greene T and Hall Y and Hebert L and Hiremath L and Jamerson K and Johnson CJ and Kopple J and Kusek J and Lash J and Lea J and Lewis JB and Lipkowitz M and Massry S and Middleton J and Miller ER 3rd and Norris K and O'Connor D and Ojo A and Phillips RA and Pogue V and Rahman M and Randall OS and Rostand S and Schulman G and Smith W and Thornley-Brown D and Tisher CC and Toto RD and Wright JT Jr and Xu S and African American Study of Kidney Disease and Hypertension (AASK) Study Group}, journal={JAMA}, volume={285}, number={21}, pages={2719-28}}"}}, {"_id": "23151750", "pmid": 23151750, "pmcid": "PMC4537064", "title": "Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis", "journal": "J Hum Hypertens", "authors": ["Bhalla M", "Aziz H", "Richard E", "Lipkowitz MS", "Bhatnagar V"], "date": "2013-06-01T00:00:00Z", "doi": "10.1038/jhh.2012.47", "meta_date_publication": "2013 Jun", "meta_volume": "27", "meta_issue": "6", "meta_pages": "393-6", "score": 50079.87, "text_hl": "The African American trial of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@Kidney disease@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ (AASK) Genomics Study (N=828) is a subset of the AASK trial that randomized 1,094 African American @SPECIES_9606 @@@men@@@ and @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@ to @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ or @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@. ", "citations": {"NLM": "Bhalla M, Aziz H, Richard E, Lipkowitz MS, Bhatnagar V. Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis J Hum Hypertens. 2013 Jun;27(6):393-6. PMID: 23151750", "BibTeX": "@article{23151750, title={Serum Potassium Predicts Time to Blood Pressure Response Among African-Americans with Hypertensive Nephrosclerosis}, author={Bhalla M and Aziz H and Richard E and Lipkowitz MS and Bhatnagar V}, journal={J Hum Hypertens}, volume={27}, number={6}, pages={393-6}}"}}, {"_id": "24958497", "pmid": 24958497, "title": "Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.", "journal": "Hypertension", "authors": ["Griffin KA", "Polichnowski A", "Litbarg N", "Picken M", "Venkatachalam MA", "Bidani AK"], "date": "2014-10-01T00:00:00Z", "doi": "10.1161/HYPERTENSIONAHA.114.03609", "meta_date_publication": "2014 Oct", "meta_volume": "64", "meta_issue": "4", "meta_pages": "801-7", "score": 50065.887, "text_hl": "Severe @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ (final 2 weeks average systolic BP, >200 mm Hg) and @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@MN@@@ (histological damage score 36+-5; n=27) developed in the untreated @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@-prone spontaneously @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_10116 @@@rats@@@ but were prevented by all antihypertensive classes (@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ [n=15], @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ [n=13], or a @CHEMICAL_Hydralazine @CHEMICAL_MESH:D006830 @@@hydralazine@@@/@CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ combination [n=15]) if the final 2-week systolic BP remained <190 mm Hg. ", "citations": {"NLM": "Griffin KA, Polichnowski A, Litbarg N, Picken M, Venkatachalam MA, Bidani AK. Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model. Hypertension. 2014 Oct;64(4):801-7. PMID: 24958497", "BibTeX": "@article{24958497, title={Critical blood pressure threshold dependence of hypertensive injury and repair in a malignant nephrosclerosis model.}, author={Griffin KA and Polichnowski A and Litbarg N and Picken M and Venkatachalam MA and Bidani AK}, journal={Hypertension}, volume={64}, number={4}, pages={801-7}}"}}, {"_id": "8889353", "pmid": 8889353, "title": "Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.", "journal": "Control Clin Trials", "authors": ["Kusek JW", "Lee JY", "Smith DE", "Milligan S", "Faulkner M", "Cornell CE", "Kopple JD", "Greene PG"], "date": "1996-08-01T00:00:00Z", "doi": "10.1016/s0197-2456(97)82681-5", "meta_date_publication": "1996 Aug", "meta_volume": "17", "meta_issue": "4 Suppl", "meta_pages": "40S-46S", "score": 50046.96, "text_hl": "Participants were randomized to either a usual mean arterial blood pressure (MAP) goal group (102-107 mm Hg) or a low-MAP goal group (< or = 92 mm Hg) and to a drug regimen (initial therapy with either @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, or @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@). ", "citations": {"NLM": "Kusek JW, Lee JY, Smith DE, Milligan S, Faulkner M, Cornell CE, Kopple JD, Greene PG. Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug;17(4 Suppl):40S-46S. PMID: 8889353", "BibTeX": "@article{8889353, title={Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.}, author={Kusek JW and Lee JY and Smith DE and Milligan S and Faulkner M and Cornell CE and Kopple JD and Greene PG}, journal={Control Clin Trials}, volume={17}, number={4 Suppl}, pages={40S-46S}}"}}, {"_id": "8889352", "pmid": 8889352, "title": "Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study.", "journal": "Control Clin Trials", "authors": ["Lee JY", "Greene PG", "Douglas M", "Grim C", "Kirk KA", "Kusek JW", "Milligan S", "Smith DE", "Whelton PK"], "date": "1996-08-01T00:00:00Z", "doi": "10.1016/s0197-2456(97)82680-3", "meta_date_publication": "1996 Aug", "meta_volume": "17", "meta_issue": "4 Suppl", "meta_pages": "34S-39S", "score": 50045.727, "text_hl": "The African American Study of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@Kidney Disease@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ (AASK) Pilot Study evaluated the feasibility of conducting a 7-year clinical trial to assess the effect of two levels of blood pressure control based on mean arterial pressure (MAP) (low goal < or = 92 mm Hg or usual goal of 102-107 mm Hg) and three antihypertensive drug regimens (@CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, or @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@) as initial therapy in slowing the @DISEASE_Cognitive_Dysfunction @DISEASE_MESH:D060825 @@@decline of renal function@@@ in African Americans with clinically diagnosed @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@. ", "citations": {"NLM": "Lee JY, Greene PG, Douglas M, Grim C, Kirk KA, Kusek JW, Milligan S, Smith DE, Whelton PK. Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. Control Clin Trials. 1996 Aug;17(4 Suppl):34S-39S. PMID: 8889352", "BibTeX": "@article{8889352, title={Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study.}, author={Lee JY and Greene PG and Douglas M and Grim C and Kirk KA and Kusek JW and Milligan S and Smith DE and Whelton PK}, journal={Control Clin Trials}, volume={17}, number={4 Suppl}, pages={34S-39S}}"}}, {"_id": "9159306", "pmid": 9159306, "title": "Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.", "journal": "Am J Kidney Dis", "authors": ["Hall WD", "Kusek JW", "Kirk KA", "Appel LJ", "Schulman G", "Agodoa LY", "Glassock R", "Grim C", "Randall OS", "Massry SG"], "date": "1997-05-01T00:00:00Z", "doi": "10.1016/s0272-6386(97)90125-6", "meta_date_publication": "1997 May", "meta_volume": "29", "meta_issue": "5", "meta_pages": "720-8", "score": 50041.1, "text_hl": "The African-American Study of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@Kidney Disease@@@ and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ pilot study randomized 94 nondiabetic black @SPECIES_9606 @@@men@@@ and @SPECIES_9606 @@@women@@@ (mean age, 53 years; 75% male) with presumed @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@ and a baseline glomerular filtration rate (GFR) of 25 to 70 mL/min/1.73 m2 (mean, 52.3 mL/min/1.73 m2) to blood pressure control at either a low mean arterial pressure (MAP) goal of < or = 92 mm Hg or a usual MAP goal of 102 to 107 mm Hg and an antihypertensive drug regimen that included either a @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ antagonist (@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@), a beta-blocker (@CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@), or an angiotensin-converting enzyme (ACE) inhibitor (@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@). ", "citations": {"NLM": "Hall WD, Kusek JW, Kirk KA, Appel LJ, Schulman G, Agodoa LY, Glassock R, Grim C, Randall OS, Massry SG. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study. Am J Kidney Dis. 1997 May;29(5):720-8. PMID: 9159306", "BibTeX": "@article{9159306, title={Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.}, author={Hall WD and Kusek JW and Kirk KA and Appel LJ and Schulman G and Agodoa LY and Glassock R and Grim C and Randall OS and Massry SG}, journal={Am J Kidney Dis}, volume={29}, number={5}, pages={720-8}}"}}, {"_id": "17059993", "pmid": 17059993, "title": "Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.", "journal": "Am J Kidney Dis", "authors": ["Norris K", "Bourgoigne J", "Gassman J", "Hebert L", "Middleton J", "Phillips RA", "Randall O", "Rostand S", "Sherer S", "Toto RD", "Wright JT Jr", "Wang X", "Greene T", "Appel LJ", "Lewis J", "AASK Study Group"], "date": "2006-11-01T00:00:00Z", "doi": "10.1053/j.ajkd.2006.08.004", "meta_date_publication": "2006 Nov", "meta_volume": "48", "meta_issue": "5", "meta_pages": "739-51", "score": 50038.527, "text_hl": "METHODS: We randomly assigned 1,094 African Americans with @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@ (glomerular filtration rate [GFR], 20 to 65 mL/min/1.73 m(2) [0.33 to 1.08 mL/s]) to initial antihypertensive treatment with either: (1) a beta-blocker, @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@; (2) an angiotensin-converting enzyme inhibitor, @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@; or (3) a @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@dihydropyridine@@@ calcium channel blocker, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, and either a usual-blood pressure (BP) or low-BP treatment goal. ", "citations": {"NLM": "Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT Jr, Wang X, Greene T, Appel LJ, Lewis J, AASK Study Group. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006 Nov;48(5):739-51. PMID: 17059993", "BibTeX": "@article{17059993, title={Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.}, author={Norris K and Bourgoigne J and Gassman J and Hebert L and Middleton J and Phillips RA and Randall O and Rostand S and Sherer S and Toto RD and Wright JT Jr and Wang X and Greene T and Appel LJ and Lewis J and AASK Study Group}, journal={Am J Kidney Dis}, volume={48}, number={5}, pages={739-51}}"}}, {"_id": "25775155", "pmid": 25775155, "pmcid": "PMC4394502", "title": "The Importance of G Protein-Coupled Receptor Kinase 4 (GRK4) in Pathogenesis of Salt Sensitivity, Salt Sensitive Hypertension and Response to Antihypertensive Treatment", "journal": "Int J Mol Sci", "authors": ["Rayner B", "Ramesar R"], "date": "2015-03-12T00:00:00Z", "doi": "10.3390/ijms16035741", "meta_date_publication": "2015 Mar 12", "meta_volume": "16", "meta_issue": "3", "meta_pages": "5741-9", "score": 50025.89, "text_hl": "The therapeutic importance of the @GENE_GRK4 @GENE_2868 @@@GRK4@@@ SNPs was emphasised in the African American Study of @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@Kidney Disease@@@ (AASK) where African-Americans with @<m>DISEASE_Nephrosclerosis</m> @DISEASE_MESH:D009400 @@@hypertensive nephrosclerosis@@@ were randomised to receive @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ or @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@. ", "citations": {"NLM": "Rayner B, Ramesar R. The Importance of G Protein-Coupled Receptor Kinase 4 (GRK4) in Pathogenesis of Salt Sensitivity, Salt Sensitive Hypertension and Response to Antihypertensive Treatment Int J Mol Sci. 2015 Mar 12;16(3):5741-9. PMID: 25775155", "BibTeX": "@article{25775155, title={The Importance of G Protein-Coupled Receptor Kinase 4 (GRK4) in Pathogenesis of Salt Sensitivity, Salt Sensitive Hypertension and Response to Antihypertensive Treatment}, author={Rayner B and Ramesar R}, journal={Int J Mol Sci}, volume={16}, number={3}, pages={5741-9}}"}}]}